Mark Maiocco
Family Medicine · Yakima, WANPI 1891703997
Payments from drug & device makers
Across 424 payments — averaging $20.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- AbbVie$979
- Pfizer$958
- Bayer$853
- Boehringer Ingelheim$676
- Novo Nordisk$566
- plus $3K from 29 others
What the payments were for
- Food & beverage$8,537100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 56 | $1,305 |
| AbbVie(2 entities) | 53 | $979 |
| Pfizer | 50 | $958 |
| Bayer | 44 | $853 |
| Boehringer Ingelheim | 28 | $676 |
| Novo Nordisk | 35 | $566 |
| GSK | 18 | $405 |
| Johnson & Johnson | 13 | $398 |
| Mylan Specialty L.p. | 16 | $284 |
| Sumitomo Pharma America, Inc. | 11 | $262 |
| Amgen | 13 | $243 |
| Esperion Therapeutics, Inc. | 13 | $142 |
| Daiichi Sankyo Inc. | 5 | $130 |
| Lilly USA, LLC | 7 | $127 |
| Novartis | 6 | $120 |
| Astellas Pharma US Inc | 5 | $102 |
| Sunovion Pharmaceuticals Inc. | 6 | $98 |
| Abbott | 3 | $98 |
| Sanofi-aventis U.S. LLC | 4 | $90 |
| Xeris Pharmaceuticals, Inc. | 4 | $86 |
| Insmed, Inc. | 4 | $85 |
| E.r. Squibb & Sons, L.L.C. | 4 | $85 |
| Kowa Pharmaceuticals America, Inc. | 5 | $73 |
| Harmony Biosciences LLC | 4 | $70 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $67 |
| Phathom Pharmaceuticals, Inc. | 3 | $35 |
| Exact Sciences | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| Biogen | 1 | $28 |
| Viatris Specialty LLC | 1 | $22 |
| Sanofi Pasteur Inc. | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
| Ironwood Pharmaceuticals, Inc | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Seqirus USA Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,537 in reported general payments places this provider in the 95th percentile of 2,275 family medicine providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RinvoqUpadacitinib | 12 | $79,392 |
| OzempicSemaglutide | 39 | $45,900 |
| EliquisApixaban | 61 | $42,336 |
| JardianceEmpagliflozin | 36 | $39,677 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 32 | $34,946 |
| FarxigaDapagliflozin Propanediol | 31 | $33,832 |
| TrulicityDulaglutide | 18 | $16,593 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $12,516 |
| Tresiba Flextouch U-200Insulin Degludec | 21 | $10,615 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 14 | $6,800 |
| Humulin 70/30 KwikpenInsulin Nph Hum/Reg Insulin Hm | 21 | $3,934 |
| Levothyroxine Sodium | 340 | $3,718 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 16 | $3,388 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $2,620 |
| Metoprolol Succinate | 100 | $2,252 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq, Creon, Synthroid | $979 | $82,98447 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $676 | $46,47750 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,305 | $46,34842 claims |
| Novo NordiskOzempic | $566 | $45,90039 claims |
| PfizerEliquis | $958 | $42,33661 claims |
| GSKTrelegy Ellipta | $405 | $34,94632 claims |
| Lilly USA, LLCTrulicity | $127 | $16,59318 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,275 family medicine providers in Washington.
Other family medicine in Yakima
- Theodore VyeYakima$17K
- Portia JonesYakima$16K
- Vani BremjitYakima$14K
- Anton GraschWenatchee$5.3M
- Gaylon KippBellevue$4.8M
- Steven KasterWenatchee$4M
- Angela EakinSpokane$3M
- Jonathan StabenCheney$2.5M
- Emily ZaragozaSeattle$1.9M
- Brad FrandsenPort Orchard$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.